INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31st May 2015
|
Net Assets |
£256m |
|
Net Assets per share |
628p |
|
Share price |
550p |
|
Total value of unquoted investments |
£19m |
|
Total number of portfolio companies |
89 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Gilead |
7.9 |
|
Amgen |
7.1 |
|
Biogen |
6.7 |
|
Celgene |
6.6 |
|
Regeneron |
6.1 |
|
Mylan |
5.8 |
|
Vertex |
3.4 |
|
Alexion |
3.2 |
|
Incyte |
3.0 |
|
Biomarin |
2.7 |
|
|
----------- |
|
Total |
52.5 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
54 |
|
Turning Profitable 2015 |
6 |
|
Unprofitable |
40 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
90 |
|
Europe & UK |
10 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
93 |
|
Unquoted |
7 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
30 JUNE 2015